Applied DNA Sciences, Inc.

COMMUNIQUÉ DE PRESSE

publié le 20/06/2024 à 15:15, il y a 5 mois 2 jours

Applied DNA and Alphazyme Conclude Linea(TM) RNAP Manufacturing Scale-up Project, Deliver Substantial Improvement in Linea(TM) IVT Platform Economics
Applied DNA and Alphazyme announce successful conclusion of Linea RNAP manufacturing scale-up agreement, resulting in over 70% cost reduction and sufficient quantity for near-term demand. Partnership enhances Linea IVT platform profitability

Biotechnology MRNA Production Alphazyme Linea RNAP Applied DNA
BRÈVE

publiée le 18/06/2024 à 15:05, il y a 5 mois 4 jours

Applied DNA s'associe à GenXys pour l'aide à la décision clinique dans les tests PGx

ADN Appliqué TR8 PGx Tests Pharmacogénomiques GenXys Prescription De Précision
BRÈVE

publiée le 18/06/2024 à 15:05, il y a 5 mois 4 jours

Applied DNA Partners with GenXys for Clinical Decision Support in PGx Testing

Applied DNA Pharmacogenomic Testing TR8 PGx GenXys Precision Prescribing
COMMUNIQUÉ DE PRESSE

publié le 18/06/2024 à 15:00, il y a 5 mois 4 jours

Applied DNA Partners with GenXys Health Care Systems to Deploy Clinical Decision Support System for Pharmacogenetic (PGx) Testing
Applied DNA partners with GenXys Health Care Systems to enhance precision prescribing decisions through TR8 PGx test. The partnership aims to improve patient outcomes and reduce healthcare costs

Healthcare Applied DNA Precision Prescribing GenXys Health Care Systems PGx Test
BRÈVE

publiée le 13/06/2024 à 15:05, il y a 5 mois 9 jours

Applied DNA reçoit l'approbation du service de tests pharmacogénomiques TR8™ du ministère de la Santé de l'État de New York

Soins De Santé Sciences Appliquées De L'ADN TR8 PGx Tests Pharmacogénomiques État De New York
BRÈVE

publiée le 13/06/2024 à 15:05, il y a 5 mois 9 jours

Applied DNA Receives Approval for TR8™ Pharmacogenomic Testing Service from New York State Department of Health

New York State Healthcare Applied DNA Sciences Pharmacogenomic Testing TR8 PGx
COMMUNIQUÉ DE PRESSE

publié le 13/06/2024 à 15:00, il y a 5 mois 9 jours

Applied DNA Receives Approval for TR8(TM) Pharmacogenomic (PGx) Testing Service from New York State Department of Health
Applied DNA Sciences, Inc. receives approval from NYSDOH for TR8 PGx testing service targeting enterprise customers and healthcare networks in New York State, offering personalized medication guidance based on genetic testing

Applied DNA Sciences Personalized Medicine Pharmacogenomic Testing TR8 PGx New York State Department Of Health
BRÈVE

publiée le 05/06/2024 à 15:05, il y a 5 mois 17 jours

Applied DNA Receives Notice of Allowance for Key U.S. Patent

Patent MRNA Production Linea IVT Applied DNA RNA Polymerase
BRÈVE

publiée le 05/06/2024 à 15:05, il y a 5 mois 17 jours

Applied DNA reçoit un avis d'acceptation pour un brevet américain clé

Brevet Production D'ARNm ADN Appliqué Ligne IVT ARN Polymérase
COMMUNIQUÉ DE PRESSE

publié le 05/06/2024 à 15:00, il y a 5 mois 17 jours

Applied DNA Announces Notice of Allowance for U.S. Patent Covering Fundamental Aspect of its Linea(TM) IVT Platform
Applied DNA Sciences, Inc. receives Notice of Allowance for patent covering Linea™ RNAP composition empowering Linea™ IVT Platform. Patent protection extends to 2041

Patent MRNA Production Applied DNA Sciences Inc. Linea™ RNAP Linea™ IVT Platform

Publié le 22/11/2024 à 17:45, il y a 2 heures 21 minutes

IMMERSION : RFA 2023/2024
Publié le 22/11/2024 à 16:15, il y a 3 heures 51 minutes

NRJ GROUP - Le Conseil d'Etat rejette le recours de NRJ 12 et NRJ GROUP
Publié le 22/11/2024 à 14:35, il y a 5 heures 31 minutes

Communiqué de presse Thales
Publié le 22/11/2024 à 14:35, il y a 5 heures 31 minutes

Thales Press release
Publié le 21/11/2024 à 06:58, il y a 1 jour 13 heures

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio

Voir tout LES ECHOS COMFI WIRE

Publié le 22/11/2024 à 18:45, il y a 1 heure 21 minutes

CORRECTING and REPLACING the Not-So-Secret Lives of REAL "Mormon" Wives - the Eye-Opening New Book From Cedar Fort Publishing & Media - is Now Available for Purchase, Just in Time for Christmas
Publié le 22/11/2024 à 16:00, il y a 4 heures 6 minutes

Manimal Tales Unveils Two New Personalized Christmas-Themed Books to Spread Holiday Magic and Joy!
Publié le 22/11/2024 à 15:55, il y a 4 heures 11 minutes

Independent Proxy Advisory Firm ISS Recommends Signal Gold Shareholders Vote for Arrangement Resolution and Private Placement Resolution
Publié le 22/11/2024 à 15:15, il y a 4 heures 51 minutes

Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment
Publié le 22/11/2024 à 14:45, il y a 5 heures 21 minutes

Jaguar Health Seeking Partner to Develop and Commercialize NP300 Second-Generation Antisecretory Prescription Drug Candidate for Treatment of General Diarrhea in Dogs

Voir tout ACCESSWIRE

Publié le 22/11/2024 à 18:14, il y a 1 heure 52 minutes

Fuller, Smith & Turner PLC: Transaction in own shares
Publié le 22/11/2024 à 18:00, il y a 2 heures 6 minutes

Holding(s) in Company
Publié le 22/11/2024 à 17:53, il y a 2 heures 13 minutes

Funding Circle Plc: POS-Transaction in Own Shares
Publié le 22/11/2024 à 16:55, il y a 3 heures 11 minutes

EQS-Adhoc: Comment on withdrawn non-binding offer
Publié le 22/11/2024 à 16:00, il y a 4 heures 6 minutes

Proposed cancellation of admission to trading

Voir tout EQS

News